title: TTP disease course is independent of myeloma treatment and response.
authors.forename: Craig C
authors.initials: CC
authors.lastname: Hofmeister
authors.forename: Ming
authors.initials: M
authors.lastname: Jin
authors.forename: Spero R
authors.initials: SR
authors.lastname: Cataland
authors.forename: Don M
authors.initials: DM
authors.lastname: Benson
authors.forename: Haifeng M
authors.initials: HM
authors.lastname: Wu
mesh_terms: D051722:ADAM Proteins / Q000037:antagonists & inhibitors / Q000172:deficiency; D000071120:ADAMTS13 Protein; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy
chemical_list: D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human